3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Rectal Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Myocarditis
1
Multiple Pulmonary Nodules
1
Liver Metastases
1
Hematologic Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Neuroendocrine
1
Carcinoma, Lobular
1
Breast Neoplasms
1
Interventions
Biopsy
8
Specimen Handling
7
Magnetic Resonance Spectroscopy
6
duvelisib
5
Cyclophosphamide
4
10-propargyl-10-deazaaminopterin
4
ruxolitinib
3
pembrolizumab
3
X-Rays
3
Vincristine
3
Etoposide
3
tazemetostat
2
sodium-iodide symporter
2
cemiplimab
2
belinostat
2
Prednisone
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Immunoglobulin G
2
Doxorubicin
2
Disulfides
2
Cytarabine
2
Bortezomib
2
Azacitidine
2
venetoclax
1
talimogene laherparepvec
1
romidepsin
1
nelarabine
1
mogamulizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
Positron Emission Tomography Computed Tomography
×
90 days
×
Clear all
No trials found.